Related Experiment Video
Updated: Jul 10, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Mechanisms of homocysteine-induced glomerular injury and sclerosis
1Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, USA.
Insights
High homocysteine levels (hHcys) contribute to kidney disease progression and end-stage renal disease (ESRD). This review explores homocysteine
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Hyperhomocysteinemia (hHcys) is a known risk factor for end-stage renal disease (ESRD) and its cardiovascular complications.
- Emerging evidence suggests hHcys directly damages glomerular cells, leading to dysfunction and sclerosis, ultimately causing ESRD.
Purpose of the Study:
- To review recent findings on homocysteine's role as a pathogenic factor in glomerular sclerosis and ESRD.
- To discuss the mechanisms by which homocysteine exerts its damaging effects in the kidney.
Main Methods:
- Literature review of recent scientific findings.
- Analysis of studies investigating homocysteine's impact on glomerular cells and kidney function.
Main Results:
- Homocysteine directly contributes to glomerular dysfunction and sclerosis.
- Key pathogenic mechanisms include oxidative stress, endoplasmic reticulum stress, homocysteinylation, and hypomethylation.
Conclusions:
- Understanding homocysteine's pathogenic mechanisms is crucial for developing targeted therapies.
- Interventions targeting hHcys may prevent kidney function decline and ESRD in at-risk populations.
Abstract:
Hyperhomocysteinemia (hHcys) has been recognized as a critical risk or pathogenic factor in the progression of end-stage renal disease (ESRD) and in the development of cardiovascular complications related to ESRD. Recently, evidence is accumulating that hHcys may directly act on glomerular cells to induce glomerular dysfunction and consequent glomerular sclerosis, leading to ESRD. In this review, we summarize recent findings that reveal the contribution of homocysteine as a pathogenic factor to the development of glomerular sclerosis or ESRD. In addition, we discuss several important mechanisms mediating the pathogenic action of homocysteine in the glomeruli or in the kidney, such as local oxidative stress, endoplasmic reticulum stress, homocysteinylation, and hypomethylation. Understanding these mechanisms may help design new approaches to develop therapeutic strategies for treatment of hHcys-associated end-organ damage and for prevention of deterioration of kidney function and ultimate ESRD in patients with hypertension and diabetes mellitus or even in aged people with hHcys.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome I : Introduction
Acute Kidney Injury II: Pathophysiology
Diabetic Nephropathy
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...

